- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Magnesium supplementation reduces fasting plasma glucose in older adults
Última actualización 30 de junio de 2026
Key finding
Magnesium supplementation significantly reduced FPG.
This study investigated the effects of magnesium oxide supplementation on glycemic control in older adults with pre-diabetes and hypomagnesemia, finding a significant reduction in fasting plasma glucose.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
This study investigated the effects of magnesium oxide supplementation on glycemic control in older adults with pre-diabetes and hypomagnesemia, finding a significant reduction in fasting plasma glucose.
Clinical relevance
Improving glycemic control in older adults with pre-diabetes is crucial to prevent the progression to type 2 diabetes. This study suggests that magnesium supplementation could be a simple and effective strategy to lower fasting plasma glucose, potentially aiding in diabetes prevention efforts.
Keep in mind
The study did not find significant changes in several key glycemic markers. The sample size and characteristics may limit generalizability. The effects on long-term diabetes outcomes remain unclear.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Jingxin Y, Huidi Z, Yuting L, et al. Magnesium Supplementation Improves Glycemic Control in Older Adults with Pre-Diabetes and Hypomagnesemia. Frontiers in Nutrition. 2026;13:1765308. doi:10.3389/fnut.2026.1765308
Efectos Principales
Magnesium supplementation significantly reduced fasting plasma glucose by -0.497 mmol/L (p=0.003).
No significant differences were observed for insulin levels.
The reduction in insulin resistance favored the magnesium group but was not statistically significant.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Magnesium oxide and C-reactive protein, Fasting Plasma Glucose (FPG), Glycated albumin, and 4 more.
This study contributes evidence to
Primary intervention
Magnesium oxide
Primary outcomes
- C-reactive protein
- Fasting Plasma Glucose (FPG)
- Glycated albumin
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
7
Evidence pairs
408
Related studies
Why it is useful
- Contributes to 7 evidence relationships
- Includes primary outcome data
- Linked to 3 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Relación de evidencia
Magnesium Supplements and Inflammatory Markers
Evidencia relacionada
Relación de evidencia
Magnesium Supplements and Fasting Glucose
Guardar evidencia
Relación de evidencia
Magnesium Supplements and HbA1c
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
Fasting Plasma Glucose (FPG)
Magnesium oxide → Fasting Plasma Glucose (FPG)
Magnesium oxide → Fasting Plasma Glucose (FPG)
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- Fasting plasma glucose decreased significantly by -0.497 mmol/L.
- No significant changes were noted in insulin or HbA1c levels.
- Insulin resistance reduction favored magnesium, but not statistically significant.
A quién se aplica
- Older adults aged 65 and above.
- Individuals diagnosed with pre-diabetes.
- Patients with low magnesium levels.
Tener en Cuenta
- Results may not be applicable to younger populations.
- The study focused on short-term effects; long-term benefits are unknown.
- Further research is needed to confirm findings across diverse populations.
Entre Líneas
- The study did not find significant changes in several key glycemic markers.
- The sample size and characteristics may limit generalizability.
- The effects on long-term diabetes outcomes remain unclear.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Magnesium Supplements and Inflammatory Markers, Magnesium Supplements and Fasting Glucose.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Magnesium Supplements → Inflammatory Markers
Supplements
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Magnesium Supplements → Fasting Glucose
Supplements
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Incluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
Fasting Glucose Evidence Hub
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
Inflammatory Markers Evidence Hub
All studies measuring Inflammatory Markers
Measures Inflammatory Markers as a key outcome.
Magnesium Supplements Evidence Hub
All studies on Magnesium Supplements
Contributes to Magnesium Supplements evidence base.
Recent Diabetes Research
Latest published studies
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Magnesium oxide and C-reactive protein
1 results
All studies on Magnesium oxide and Fasting Plasma Glucose (FPG)
1 results
All studies on Magnesium oxide
1 results
All studies measuring C-reactive protein
1 results
All studies measuring Fasting Plasma Glucose (FPG)
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Magnesium Supplements improve inflammatory markers?
Current evidence does not show a clear benefit of Magnesium Supplements for Inflammatory Markers.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
C-reactive protein
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
- 2
Interleukin-6 (IL-6)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
- Only a small number of supporting studies are available.
- Population details are unavailable.
Does Magnesium Supplements improve insulin resistance?
Current evidence does not show a clear benefit of Magnesium Supplements for Insulin Resistance.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Insulin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
- 2
Insulin resistance
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Magnesium Supplements improve fasting glucose?
Magnesium Supplements appears to improve Fasting Glucose.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Fasting Plasma Glucose (FPG)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Magnesium Supplements improve HbA1c?
Current evidence does not show a clear benefit of Magnesium Supplements for HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.
